Effect of topical honey application along with intralesional injection of glucantime in the treatment of the cutaneous leishmaniasis

Not Applicable

Completed

• Conditions: Cutaneous leishmaniasis; Infections and Infestations; Leishmaniasis

• Registration Number: ISRCTN12004149
• Lead Sponsor: Skin Disease and Leishmaniasis Research Center (Iran)

Brief Summary

Results: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17466071

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2005-10-22
• Study Start: 2006-11-13
• Last Update Posted: 10 February 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

1. Confirmed cutaneous leishmaniasis with direct smear
2. No history of systemic or topical therapy for cutaneous leishmaniasis
3. Absence of the malnutrition or severe predisposing disease such as cardiac, renal or hepatic disease and other contraindication for glucantime

Exclusion Criteria

N/A

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Curing of the leishmaiasis

Secondary Outcome Measures

Name	Time	Method
Diameter of the lesion and size of the erythema, induration and ulcer